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Abstract
We study microwave scattering spectra of metallic stents in open air. We show that they behave
like dipole antennas in terms of microwave scattering and they exhibit characteristic resonant
frequencies for a given nominal size. We obtain a fair agreement between measured frequencies
and the values provided by a theoretical model for dipole antennas. This fact opens the door to
obtaining methods to detect structural distortions of stents within in vitro conditions. Finally we
discuss the in vivo applicability of the suggested method in terms of our theoretical model and the
skin depth of microwaves in biological tissues.
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I. INTRODUCTION
A coronary stent [1, 2] is a medical prosthetic device shaped as a small cylindrical tube
with wire mesh walls, which is used to rehabilitate atherosclerotic stenosed coronary arteries.
The first generation of coronary stents, conventional bare-metal stents, was developed in
the mid-1980s [3]. Despite their obvious advantages in-stent neointimal hyperplasia [4–6]
occurred in some cases. This phenomenon, also known as in-stent restenosis, was directly
linked to stent implantation and resulted in restenosis rates of 20% to 30% [7]. It was
the attempt to minimize this problem, and thereby reduce rates of repeat revascularization,
that ultimately lead to the development of another revolutionary treatment: the drug-eluting
stents. The dramatic reduction in restenosis rates seen with the use of these drug-eluting
stents compared with bare-metal stents [8–12] has been the major driving force behind the
exponential growth of percutaneous coronary interventions as a treatment for patients with
coronary artery disease.
However, even with such improvements, patients with coronary stents require chronic
medication and monitoring. For this reason considerable effort has been made to improve
their quality of life. On the one hand, research has been carried out to improve the design
of stents. Promising examples are biodegradable stents [13] or devices allowing wireless
monitoring of pressure and blood flow [14, 15]. Manufacturing methods based on microelec-
trodischarge machining have also been suggested [16]. On the other hand, work is being
conducted for the optimization of medical imaging techniques aiming for real-time high-
quality images with minimal damage to the patient. These include non-invasive techniques
such as magnetic resonance [17] and duplex ultrasound [18] as well as invasive methods
such as X-ray angiography [19], intravascular ultrasound [20], intravascular photoacoustic
imaging [21] and optical coherence tomography [22]. In spite of the obvious clinical benefits,
these techniques require high costs and justification of potential patient collateral damages,
like impact of invasive procedures or ionizing radiation dose.
Physicians have widely studied the medical risks arising from the structural distortion
of stents. In particular, stent recoil [23] and fracture [24, 25] involve respectively dras-
tic changes in diameter and length that could imply serious consequences. We show here
that stents exhibit characteristic resonant frequencies in their microwave absorbance spectra
which provide relevant information regarding their dimensions and should therefore reflect
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FIG. 1: (Color online). Sketch of the experimental set-up. The inset shows a detail of the geomet-
rical configuration for the characterization of stents.
the occurrence of such structural distortions.
II. EXPERIMENTAL METHODS
Figure 1 shows a sketch of the experimental set-up used in the present work. In vitro
microwave absorbance spectra were measured in open air for thirty commercial drug-eluting
stents [26] of different nominal length ` and diameter φ. To obtain the spectra a pair of
right-handed circularly-polarized cavity-backed spiral antennas [27] was connected to a 2-
port vector network analyzer [28] via coaxial feed lines. The antennas have a 2.0 - 18.0
GHz spectral range. This set-up provides the transmission coefficient of port 1 to port 2
as a function of frequency, S12 (f), or vice versa S21 (f), from which we can calculate the
absorbance spectrum as
A (f) = 10 log
(
Sref (f)
S (f)
)
, (1)
where S (f) and Sref (f) respectively denote the transmission coefficients measured as a
function of frequency with and without a stent, and subindices have been dropped for
simplicity. Results were obtained from the average of 100 acquisitions of both magnitudes.
Measurements were performed in a symmetrical configuration in which the center of the
stent was placed at the midpoint of the line joining the two antennas (optical axis), which
are set at a constant separation of 16 cm. The stents were positioned with the aid of an
expanded polystyrene sample holder which allows to rotate the stent longitudinal axis (stent
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axis) at an azimuth angle ϕ around a vertical axis that is perpendicular to the optical axis
(see the inset in Figure 1). A (f) spectra were obtained at 4◦ steps over a complete rotation
of each stent around the vertical axis.
III. RESULTS AND DISCUSSION
Figure 2(a) shows typical A (f) spectra obtained at two values of ϕ for a stent of well-
defined dimensions. Similar spectra were obtained at any ϕ value for the thirty stents
investigated. Discrete resonant frequencies with quality factors close to 20 are exhibited
by both spectra. Although up to five orders of resonance were detected, we focus here on
the characterization of the first two, f1 and f2. All first orders on the one hand, and all
second orders on the other, shared the same features for each studied stent. Figures 2(b)
and 2(c) present respectively the azimuthal dependence of the amplitude of the first two
resonances, A1 (ϕ) and A2 (ϕ), for four stents with the same diameter and different lengths.
A1 (ϕ) shows a bilobular pattern, with peaks occurring when the stent axis is perpendicular
to the optical axis, while A2 (ϕ) shows a tetralobular pattern, with peaks occurring when
ϕ is in the range 32◦ - 40◦. Higher resonances show more complex A (ϕ) dependences, like
hexalobular patterns for f3, for example. The ability to discern these resonances by means
of the inspection of their A (ϕ) patterns allows to create a database with their values for
each stent. Figure 3 shows f1 and f2 as a function of ` for several φ values of the thirty
stents investigated. Notice how both frequencies are inversely proportional to ` and roughly
proportional to φ.
The shapes of the experimental curves in Figures 2(b) and 2(c) closely resemble gain
patterns of a center-feed half-wave dipole antenna [29]. This fact, along with the 1/` de-
pendence shown in Figure 3, suggests that the microwave scattering of stents is remarkably
similar to that produced by such device [30]. The microwave electromagnetic field couples
here to the antenna conductive structure and induces a standing electric current along it.
Consequently the scattering is enhanced at resonant frequencies given by [31]
fn(L) =
n
2L
√
µ
, (2)
where  and µ are respectively the permittivity and permeability of the stent surrounding
medium, L is the dipole antenna length, and n is the resonance mode. We found out that the
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resonant frequencies in a stent of length ` are significantly lower than those corresponding
to a dipole antenna with L = `. This means that, in terms of microwave scattering, metallic
stents of length ` behave akin to dipole antennas of length L = a`, where a is a scaling
factor. As an example, in Figure 3 we have plotted Equation 2 for a = 1.8. There is an ac-
ceptable agreement between experimental resonant frequencies and theoretical estimations.
The presence of a scaling factor greater than one should be considered reasonable due to the
characteristic folded structure of coronary stents. The precise value of this scaling factor
would actually give a hint about the folding degree of a particular stent architecture.
These results show that a method for the detection of structural distortions of stents by
measuring their resonant frequencies is possible, at least under in vitro conditions. We will
then discuss the in vivo applicability of this method in terms of the skin depth of microwaves
in the human body. Due to the 1/
√
µ factor of Equation 2, it is expected that the in vitro
resonant frequencies of stents will shift down with respect to the in vivo frequencies, since
the relative permittivity of biological tissues in the microwave range is higher than one. We
can thus obtain the relation between the in vitro and in vivo values, f ′ and f respectively,
using Equation 2 and assuming air as the surrounding in vitro medium of the stent,
f ′(f) = cf
√
(f)µ(f). (3)
Introducing the dependences of (f) and µ(f) given by parametric models [32] in Equation
3, f ′(f) may be determined numerically. Figure 4(a) shows such dependence for several
representative tissues and highlights that the shift between f ′ and f is of about one order
of magnitude.
Conduction and displacement currents induced by electromagnetic waves are of the same
order for most biological tissues [33], so in this case the skin depth for media limited by
plane boundaries is generally expressed as [34]
δ(f) =
1
2pif
12µ(f)(f)
√1 + ( σ(f)
2pif(f)
)2
− 1

−1/2
, (4)
where σ is the conductivity of the medium. Using again parametric models [32], we can
determine numerically δ(f). Figure 4(b) shows that δ(f) is found to be of several tens of
millimeters for in vivo operating frequencies. This fact demonstrates that microwaves travel
through the thoracic cavity and reach the heart, thereby enabling the medical applicability
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of microwave spectrometry for the evaluation of the dimensions of implanted coronary stents.
IV. CONCLUSIONS
We have proved experimentally that metallic stents of a given nominal length and diame-
ter exhibit characteristic resonant frequencies in their open air microwave scattering spectra.
We have also proposed a simple theoretical model based on a dipole antenna that allows
to estimate the values of such frequencies. It is expected that some structural distortions
experienced by implanted stents due to aging should be reflected in a variation of the res-
onant frequencies. Finally, we have estimated the in vivo frequency band corresponding to
the in vitro frequencies of the investigated stents and its associated skin depth range for
several representative tissues, demonstrating the medical applicability of the method here
discussed. Our work will allow the achievement of techniques able to prevent alterations,
such as stent recoil or fracture, that nowadays have strong medical impact. Characteriza-
tion of stents with induced geometrical distortions within biological tissue mimics are under
development. Further experiments will include ex vivo and in vivo trials. We hope that our
work will stimulate the development of non-invasive and non-ionizing intensive monitoring
medical techniques of patients with coronary stents.
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FIG. 2: (Color online) (a) Absorbance spectra, A (f), of a drug-eluting stent (2.50 mm in diameter
and 30 mm in length) at 0◦ and 40◦ values of ϕ (solid and dotted line, respectively). (b) and (c)
Angular dependence of absorbance for the first two resonances, A1 (ϕ) and A2 (ϕ), respectively, of
four drug-eluting stents with the same diameter (2.50 mm) and different lengths from 14 to 30 mm
(see legend for symbol details).
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FIG. 3: (Color online) Measured characteristic resonant frequencies as a function of length `
for several diameters φ of the thirty drug-eluting stents investigated. Solid and open symbols
correspond respectively to the first (f1) and second (f2) experimental modes. The solid and dotted
lines represent respectively the first and second theoretical modes given by Equation 2 for a scaling
factor a = 1.8.
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FIG. 4: (Color online) (a) Relation between the in vitro and in vivo resonant frequencies, f ′(f),
of the studied stents for four representative human biological tissues (see legend for details). (b)
Skin depth as a function of frequency, δ(f), for the same four tissues. The shaded area highlights
the range of f (in vivo frequency band) associated to the typical range of f ′ (in vitro frequency
band) enclosing the first mode resonant frequencies of the measured stents.
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